pharma · Pulmonary Arterial Hypertension (PAH)
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals GmbH
AOP Orphan Pharmaceuticals patent portfolio — 7 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Wien, AT
- Programs
- 2
- Drugs
- 1
- Patents
- 7
AOP Orphan Pharmaceuticals patents
7 pharmaceutical patents indexed for AOP Orphan Pharmaceuticals. 0 expire within 24 months.
AOP Orphan Pharmaceuticals has 7 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
WO 2025172541
NOUVELLE COMPOSITION POUR L'AMÉLIORATION DE LA RECONSTITUTION DE LA MOELLE OSSEUSE ET DE LA RÉCUPÉRATION PÉRIPHÉRIQUE DES NUMÉRATIONS DE NEUTROPHILES ET DE PLAQUETTES
granted -
WO 2025153663
LANDIOLOL COMPLEXÉ ENCAPSULÉ OU DISSOUS DANS UNE MATRICE LIPOPHILE
granted -
LT 3544598
CANNABINOIDS FOR PROPHYLACTIC TREATMENT OF INVOLUNTARY WEIGHT LOSS
granted -
EP 2988750
VERWENDUNG VON LANDIOLOLHYDROCHLORID BEI DER LANGZEITBEHANDLUNG VON TACHYARRHYTHMIEN
granted -
AU 2013258031
Parenteral esmolol formulation
granted -
AU 2009324043
Novel composition for treatment of essential thrombocythemia
granted -
AU 2008340179
Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists
granted
Frequently asked questions
How many patents does AOP Orphan Pharmaceuticals have?
7 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do AOP Orphan Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.